BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 27, 2019
View Archived Issues
Indirect targeting can affect serine production
Read More
Thai vaccine works better in South Africa
Read More
Targeting genes while avoiding their homologues can fix CGD
Read More
Lymphocytes check brain's privilege
Read More
NR4A1AS lncRNA regulates NR4A1 expression promoting colorectal cancer tumor growth and metastasis
Read More
DG-12P1 identified as first AI-discovered therapeutic candidate
Read More
Inflazome begins first-in-human study of IZD-334 for CAPS
Read More
New phase I trial of IGM-2323 enrolling patients with relapsed or refractory B-cell NHL
Read More
Study reports new insight into, target for Krabbe disease
Read More
BAL-101553 treatment associated with inhibition of CSLC-mediated tumor angiogenesis in vivo
Read More
Dual CB1R/iNOS antagonist MRI-1867 ameliorates obesity-induced CKD in vivo
Read More
FABP4 as a novel biochemical marker in diabetic ketoacidosis in children
Read More
TRPC4AP identified as gene biomarker candidate in thyroid dysgenesis
Read More
FDA authorizes first-in-human clinical trial of AZD-0466
Read More
First patient dosed in phase IIb ICONA study of icosabutate
Read More
Immunicum presents complete topline data from phase II MERECA study
Read More
Immutep announces positive interim data from TACTI-002 phase II study
Read More
GlaxoSmithKline and ViiV Healthcare patent new compounds for HIV
Read More
Zeno Royalties & Milestones presents WEE1hu inhibitors
Read More
Amgen identifies Mcl-1 inhibitors
Read More
Pliant Therapeutics describes integrin alphavbeta6 antagonists
Read More
New TYK2 inhibitors detailed in AbbVie patent
Read More
FDA approves Jynneos for prevention of smallpox and monkeypox disease in adults
Read More
Clinical phase IIa data on RNS-60 for multiple sclerosis presented
Read More
NIDA award to support Ensysce's development of opioid use disorder product
Read More
Phase II study of ganaxolone in refractory status epilepticus meets primary endpoint
Read More
Galmed initiates phase III/IV study of aramchol in patients with NASH and fibrosis
Read More
Curevo reports preliminary phase I data on shingles vaccine candidate CRV-101
Read More
European Commission approves Trogarzo for HIV-1
Read More